RxSight (RXST) Assets (2020 - 2026)

RxSight's Assets history runs 7 years deep, the most recent figure standing at $304.0 million for Q1 2026.

• Quarterly Assets fell 2.89% year-over-year to $304.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $304.0 million (down 2.89% YoY) and the FY2025 annual result came in at $311.8 million, down 2.12% from the prior year.
• Assets was $304.0 million for Q1 2026 at RxSight, down from $311.8 million in the prior quarter.
• Across five years, Assets topped out at $318.6 million in Q4 2024 and bottomed at $150.2 million in Q4 2022.
• A 5-year average of $239.8 million and a median of $202.5 million in 2023 frame the typical range for Assets.
• Peak annual rise in Assets reached 75.7% in 2022, while the deepest fall reached 23.57% in 2022.
• RxSight's Assets stood at $150.2 million in 2022, then rose by 21.57% to $182.5 million in 2023, then surged by 74.51% to $318.6 million in 2024, then declined by 2.12% to $311.8 million in 2025, then fell by 2.51% to $304.0 million in 2026.
• Business Quant data shows RXST's Assets at $304.0 million in Q1 2026, $311.8 million in Q4 2025, and $308.5 million in Q3 2025.